Liven Pharma (KAR:LIVEN) Research & Development: ₨ Mil (TTM As of . 20)


What is Liven Pharma Research & Development?

Liven Pharma KAR:LIVEN -1.33% Research & Development is ₨ Mil as of . 20. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Liven Pharma's Research & Development for the six months ended in . 20 was ₨0.00 Mil. Liven Pharma does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.


Liven Pharma  (KAR:LIVEN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Liven Pharma Research & Development Related Terms


Liven Pharma Research & Development Historical Data

* Premium members only.

The historical data trend for Liven Pharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Liven Pharma Research & Development Chart

Liven Pharma Annual Data
Trend
Research & Development

Liven Pharma Semi-Annual Data
Research & Development

Liven Pharma Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₨ Mil mean?
Liven Pharma (KAR:LIVEN) has a Research & Development of ₨ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Liven Pharma and its competitors.
Is Liven Pharma's Research & Development too high?
Liven Pharma's current Research & Development is ₨ Mil.
How does Liven Pharma's Research & Development compare to AIN?
Liven Pharma's Research & Development of ₨ Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Manufacturing - Apparel & Accessories company?
A good Research & Development depends on the Manufacturing - Apparel & Accessories industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Liven Pharma and its competitors. Liven Pharma's current Research & Development is ₨ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liven Pharma stock overvalued right now?
Liven Pharma (KAR:LIVEN) has a current Research & Development of ₨ Mil. The current Research & Development is ₨ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Liven Pharma (KAR:LIVEN), the current Research & Development is ₨ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Liven Pharma Business Description

Address I.I Chundrigar Road, 1st Floor, The Cotton Exchange Building, Karachi, SD, PAK, 75350
Liven Pharma Ltd, formerly Landmark Spinning Industries Ltd is engaged in trading, manufacturing, and sale of yarn.